Panagopoulou, M.; Drosouni, A.; Fanidis, D.; Karaglani, M.; Balgkouranidou, I.; Xenidis, N.; Aidinis, V.; Chatzaki, E.
ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker. Int. J. Mol. Sci. 2022, 23, 3717.
https://doi.org/10.3390/ijms23073717
AMA Style
Panagopoulou M, Drosouni A, Fanidis D, Karaglani M, Balgkouranidou I, Xenidis N, Aidinis V, Chatzaki E.
ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker. International Journal of Molecular Sciences. 2022; 23(7):3717.
https://doi.org/10.3390/ijms23073717
Chicago/Turabian Style
Panagopoulou, Maria, Andrianna Drosouni, Dionysiοs Fanidis, Makrina Karaglani, Ioanna Balgkouranidou, Nikolaos Xenidis, Vassilis Aidinis, and Ekaterini Chatzaki.
2022. "ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker" International Journal of Molecular Sciences 23, no. 7: 3717.
https://doi.org/10.3390/ijms23073717
APA Style
Panagopoulou, M., Drosouni, A., Fanidis, D., Karaglani, M., Balgkouranidou, I., Xenidis, N., Aidinis, V., & Chatzaki, E.
(2022). ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker. International Journal of Molecular Sciences, 23(7), 3717.
https://doi.org/10.3390/ijms23073717